• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG ORSIRO MISSION US 3.0/30; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG ORSIRO MISSION US 3.0/30; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 453964
Medical Device Problem Code Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/20/2026
Type of Reportable Event Malfunction
Event or Problem Description
The orsiro mission drug-eluting stent system was selected for treatment of a severely calcified lesion in a severely tortuous segment of the ostial cx.While inserting the orsiro mission, the stent buckled on itself, still on the balloon.After removal from body, the stent is still intact on balloon.A stent from another manufacturer was used to complete the intervention.
 
Additional Manufacturer Narrative
Combination product: yes.
 
Additional Manufacturer Narrative
Combination product: yes the returned product was subjected to a technical analysis and the corresponding production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.The technical investigation of the returned device revealed that the stent is deformed at its proximal end.Several stent struts are deformed (i.E., crushed, compressed, everted).Microscopic analysis revealed stent imprints on the exposed balloon surface, indicating that the bent struts were initially crimped on the balloon.Outside of the deformed zone the crimped diameter of the stent complies with the specification.Review of the production documentation confirmed that the product was manufactured according to specifications and passed all in-process and final inspections.During final inspection, every stent system undergoes visual inspection to ensure correct stent embedding and homogeneous crimping of the stent.Based on the conducted investigations of the device being subject to this complaint, no material or manufacturing related root cause could be determined.
 
Event or Problem Description
The orsiro mission drug-eluting stent system was selected for treatment of a severely calcified lesion in a severely tortuous segment of the ostial cx.While inserting the orsiro mission, the stent buckled on itself, still on the balloon.After removal from body, the stent is still intact on balloon.A stent from another manufacturer was used to complete the intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO MISSION US 3.0/30
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG
ackerstrasse 6
bulach, zurich 8180
SZ  8180
Manufacturer (Section G)
BIOTRONIK AG
ackerstrasse 6
bulach, zurich 8180
SZ   8180
Manufacturer Contact
ramona ergler
ackerstrasse 6
bulach, zurich 8180
SZ   8180
MDR Report Key24427059
Report Number8043892-2026-02022
Device Sequence Number21360594
Product Code NIQ
UDI-Device Identifier07640130456204
UDI-Public(01)07640130456204(17)280920(10)08253083
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source User Facility,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 04/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number453964
Device Lot Number08253083
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/13/2026
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/02/2026
Supplement Date Received by Manufacturer02/02/2026
Initial Report FDA Received Date02/24/2026
Supplement Report FDA Received Date04/07/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/22/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-